Simple method for the assay of clindamycin in human plasma by reversed-phase high-performance liquid chromatography with UV detector

Biomedical Chromatography

Volumn 19, Issue 10, 2005, Pages 783-787

  Cho, Sung Hee ^a   Im, Ho Taek ^a   Park, Wan Su ^a   Ha, Yong Hwa ^a   Choi, Young Wook ^b   Lee, Kyung Tae ^a  

^a Kyung Hee University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Bioavailability; Clindamycin; HPLC; Human plasma

Indexed keywords

BIOCHEMISTRY; CHLORINE COMPOUNDS; PLASMA (HUMAN); PLASMA STABILITY; TRICHLOROACETIC ACID;

BIOAVAILABILITY; CLINDAMYCIN; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN PLASMAS; INTERNAL STANDARDS; PLASMA SAMPLES; REVERSE PHASIS; REVERSED-PHASE HIGH PERFORMANCE; SIMPLE METHOD; SIMPLE++;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ACETONITRILE; CLINDAMYCIN; PROPRANOLOL; TETRAMETHYLAMMONIUM CHLORIDE; TRICHLOROACETIC ACID;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; COLUMN CHROMATOGRAPHY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PH MEASUREMENT; PHASE SEPARATION; PRECIPITATION; QUANTITATIVE ANALYSIS; RADIATION DETECTION; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 29544445267     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.517     Document Type: Article

References (14)

1. Batzias GC, Delis GA and Koutsoviti-Papadopoulou M. A new HPLC/UV method for the determination of clindamycin in dog blood serum. Journal of Pharmaceutical and Biomedical Analysis 2004; 35: 545.
2. Cherlet M, Croubels S and De Backer P. Determination of clindamycin in animal plasma by high-performance liquid chromatography combined with electrospray ionization mass spectrometry. Journal of Mass Spectrometry 2002; 37: 848.
3. Duckworth C, Fisher JF, Carter SA, Newman CL, Cogburn C, Nesbit RR and Wray CH. Tissue penetration of clindamycin in diabetic foot infections. Journal of Antimicrobial Chemotherapy 1993; 31: 581.
4. Fieger-Büschges H, Schussler G, Larsimont V and Blume H. Determination of clindamycin in human plasma by high-performance liquid chromatography using coupled columns. Journal of Chromatography Biomedical Science Applications 1999; 724: 281.
5. Gatti G, Flaherty J, Bubp J, White J, Borin M and Gambertoglio J. Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS. Journal of Antimicrobial Agents and Chemotherapy 1993; 37: 1137.
6. Itrud FB, Gabriele S, Véronique L and Henning B. Determination of clindamycin in human plasma by high-performance liquid chromatography using coupled columns. Journal of Chromatography B 1999; 724: 281.
7. La Follette G, Gambertoglio J, White JA, Knuth DW and Lin ET. Determination of clindamycin in plasma or serum by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography 1988; 431: 379.
8. Liu CM, Chen YK, Yang TH, Hsieh SY, Hung MH and Lin ET. High-performance liquid chromatographic determination of clindamycin in human plasma or serum: application to the bio-equivalency study of clindamycin phosphate injections. Journal of Chromatography B 1997; 696: 298.
9. Martens-Lobenhoffer J and Banditt P. Sensitive and specific determination of clindamycin in human serum and bone tissue applying liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. Journal of Chromatography B 2001; 755: 143.
10. Metzler CM, DeHaan R, Schellenberg D and Vandenbosch WD. Clindamycin dose-bioavailability relationships. Journal of Pharmaceutical Science 1973; 62: 591.
11. Phillips I. Clinical used and control of rifampicin and clindamycin. Journal of Clinical Pathology 1971; 24: 410.
12. Rechberger GN, Fauler G, Windischhofer W, Kofeler H, Erwa W and Leis HJ. Quantitative analysis of clindamycin in human plasma by liquid chromatography/electrospray ionisation tandem mass spectrometry using d1-N-ethylclindamycin as internal standard. Rapid Communications in Mass Spectrometry 2003; 17: 135.
13. Sweetman SC. Martindale 33. Pharmaceutical Press: London, 2002; 188.
14. Yu LL, Chao CK, Liao WJ, Twu TY, Liu CM, Yang TH and Lin ET. Determination of clindamycin in human plasma by liquid chromatography-electrospray tandem mass spectrometry: Application to the bioequivalence study of clindamycin. Journal of Chromatography B 1999; 724: 287.